Toei Shinyaku Co., Ltd. obtained two U.S. patents for β-glucan measurement technologies developed through collaborative research on outdoor-cultivated Agaricus KA21 with the Department of Immunology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences.
The patented technologies concern methods for measuring β-glucans, which are major structural components found in fungi, including mushrooms. The research was conducted as part of Toei Shinyaku’s long-term scientific investigation of Agaricus KA21.
The corresponding technologies have also been patented in Japan.
Toei Shinyaku has conducted research on outdoor-cultivated Agaricus KA21 for more than 30 years and continues to develop scientific evidence and intellectual property through collaboration with universities and research institutions.
Agaricus KA21 is derived from outdoor-cultivated Agaricus brasiliensis and is commercially known as King Agaricus KA21.
Details
U.S. Patents: US 11,479,803 B2; US 11,542,307 B2
Corresponding Japanese Patents: Patent No. 7052967; Patent No. 6966756
Research Partner: Department of Immunology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
Related Press Releases
- U.S. Patent US 11,479,803 B2 — Japanese Press Release
- U.S. Patent US 11,542,307 B2 — Japanese Press Release
